237 related articles for article (PubMed ID: 31254204)
1. Analyses of biomarkers of exposure to nephrotoxic mycotoxins in a cohort of patients with renal tumours.
Malir F; Louda M; Ostry V; Toman J; Ali N; Grosse Y; Malirova E; Pacovsky J; Pickova D; Brodak M; Pfohl-Leszkowicz A; Degen GH
Mycotoxin Res; 2019 Nov; 35(4):391-403. PubMed ID: 31254204
[TBL] [Abstract][Full Text] [Related]
2. Biomonitoring of concurrent exposure to ochratoxin A and citrinin in pregnant women in Bangladesh.
Ali N; Blaszkewicz M; Manirujjaman M; Degen GH
Mycotoxin Res; 2016 Aug; 32(3):163-72. PubMed ID: 27185052
[TBL] [Abstract][Full Text] [Related]
3. Biological monitoring for ochratoxin A and citrinin and their metabolites in urine samples of infants and children in Bangladesh.
Ali N; Degen GH
Mycotoxin Res; 2020 Nov; 36(4):409-417. PubMed ID: 32820428
[TBL] [Abstract][Full Text] [Related]
4. Urinary biomarkers of ochratoxin A and citrinin exposure in two Bangladeshi cohorts: follow-up study on regional and seasonal influences.
Ali N; Blaszkewicz M; Alim A; Hossain K; Degen GH
Arch Toxicol; 2016 Nov; 90(11):2683-2697. PubMed ID: 26705708
[TBL] [Abstract][Full Text] [Related]
5. Blood plasma biomarkers of citrinin and ochratoxin A exposure in young adults in Bangladesh.
Ali N; Hossain K; Degen GH
Mycotoxin Res; 2018 Mar; 34(1):59-67. PubMed ID: 29143924
[TBL] [Abstract][Full Text] [Related]
6. Human biomonitoring of multiple mycotoxins in the Belgian population: Results of the BIOMYCO study.
Heyndrickx E; Sioen I; Huybrechts B; Callebaut A; De Henauw S; De Saeger S
Environ Int; 2015 Nov; 84():82-9. PubMed ID: 26233555
[TBL] [Abstract][Full Text] [Related]
7. First results on citrinin biomarkers in urines from rural and urban cohorts in Bangladesh.
Ali N; Blaszkewicz M; Mohanto NC; Rahman M; Alim A; Hossain K; Degen GH
Mycotoxin Res; 2015 Feb; 31(1):9-16. PubMed ID: 25488509
[TBL] [Abstract][Full Text] [Related]
8. Biomonitoring of ochratoxin A, 2'R-ochratoxin A and citrinin in human blood serum from Switzerland.
Jaus A; Rhyn P; Haldimann M; Brüschweiler BJ; Fragnière Rime C; Jenny-Burri J; Zoller O
Mycotoxin Res; 2022 May; 38(2):147-161. PubMed ID: 35446004
[TBL] [Abstract][Full Text] [Related]
9. Methods for analysis of citrinin in human blood and urine.
Blaszkewicz M; Muñoz K; Degen GH
Arch Toxicol; 2013 Jun; 87(6):1087-94. PubMed ID: 23354378
[TBL] [Abstract][Full Text] [Related]
10. Toxicity of the mycotoxin citrinin and its metabolite dihydrocitrinone and of mixtures of citrinin and ochratoxin A in vitro.
Föllmann W; Behm C; Degen GH
Arch Toxicol; 2014 May; 88(5):1097-107. PubMed ID: 24577378
[TBL] [Abstract][Full Text] [Related]
11. Fast and sensitive LC-MS/MS method measuring human mycotoxin exposure using biomarkers in urine.
Huybrechts B; Martins JC; Debongnie P; Uhlig S; Callebaut A
Arch Toxicol; 2015 Nov; 89(11):1993-2005. PubMed ID: 25209565
[TBL] [Abstract][Full Text] [Related]
12. Biomonitoring of Mycotoxins in Urine: Pilot Study in Mill Workers.
Föllmann W; Ali N; Blaszkewicz M; Degen GH
J Toxicol Environ Health A; 2016; 79(22-23):1015-1025. PubMed ID: 27924714
[TBL] [Abstract][Full Text] [Related]
13. Preliminary data on citrinin kinetics in humans and their use to estimate citrinin exposure based on biomarkers.
Degen GH; Ali N; Gundert-Remy U
Toxicol Lett; 2018 Jan; 282():43-48. PubMed ID: 29030270
[TBL] [Abstract][Full Text] [Related]
14. Assessment of multiple mycotoxin exposure and its association with food consumption: a human biomonitoring study in a pregnant cohort in rural Bangladesh.
Kyei NNA; Cramer B; Humpf HU; Degen GH; Ali N; Gabrysch S
Arch Toxicol; 2022 Jul; 96(7):2123-2138. PubMed ID: 35441239
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous analysis of ochratoxin A and its major metabolite ochratoxin alpha in plasma and urine for an advanced biomonitoring of the mycotoxin.
Muñoz K; Blaszkewicz M; Degen GH
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(27):2623-9. PubMed ID: 20031488
[TBL] [Abstract][Full Text] [Related]
16. Mycotoxins in blood and urine of Swedish adolescents-possible associations to food intake and other background characteristics.
Warensjö Lemming E; Montano Montes A; Schmidt J; Cramer B; Humpf HU; Moraeus L; Olsen M
Mycotoxin Res; 2020 May; 36(2):193-206. PubMed ID: 31838651
[TBL] [Abstract][Full Text] [Related]
17. New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor.
Pfohl-Leszkowicz A; Tozlovanu M; Manderville R; Peraica M; Castegnaro M; Stefanovic V
Mol Nutr Food Res; 2007 Sep; 51(9):1131-46. PubMed ID: 17729220
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous LC-MS/MS determination of aflatoxin M1, ochratoxin A, deoxynivalenol, de-epoxydeoxynivalenol, α and β-zearalenols and fumonisin B1 in urine as a multi-biomarker method to assess exposure to mycotoxins.
Solfrizzo M; Gambacorta L; Lattanzio VM; Powers S; Visconti A
Anal Bioanal Chem; 2011 Nov; 401(9):2831-41. PubMed ID: 21892639
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of the mycotoxin citrinin and its metabolite dihydrocitrinone in urines of German adults.
Ali N; Blaszkewicz M; Degen GH
Arch Toxicol; 2015 Apr; 89(4):573-8. PubMed ID: 25224402
[TBL] [Abstract][Full Text] [Related]
20. Reviewing the Analytical Methodologies to Determine the Occurrence of Citrinin and its Major Metabolite, Dihydrocitrinone, in Human Biological Fluids.
Silva L; Pereira A; Duarte S; Pena A; Lino C
Molecules; 2020 Jun; 25(12):. PubMed ID: 32599786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
